Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee. by Blijenberg, BG, Lilja, H, Neels, H, Stenman, U

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer. by Bangma, C, van Schaik, R, Blijenberg, BG, Roobol, M, Lilja, H, Stenman, U

Screening and prostate-cancer mortality in a randomized European study. by Schröder, F, Hugosson, J, Roobol, M, Tammela, T, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, L, Recker, F, Berenguer, A, Määttänen, L, Bangma, C, Aus, G, Villers, A, Rebillard, X, van der Kwast, T, Blijenberg, BG, Moss, S, de Koning, H, Auvinen, A

Prostate-cancer mortality at 11 years of follow-up. by Schröder, F, Hugosson, J, Roobol, M, Tammela, T, Ciatto, S, Nelen, V, Kwiatkowski, M, Lujan, M, Lilja, H, Zappa, M, Denis, L, Recker, F, Páez, A, Määttänen, L, Bangma, C, Aus, G, Carlsson, S, Villers, A, Rebillard, X, van der Kwast, T, Kujala, P, Blijenberg, BG, Stenman, U, Huber, A, Taari, K